These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Extravasation of systemic hemato-oncological therapies. Ener RA; Meglathery SB; Styler M Ann Oncol; 2004 Jun; 15(6):858-62. PubMed ID: 15151940 [TBL] [Abstract][Full Text] [Related]
25. [Soft-tissue defects on the dorsum of the hand by extravasation of the cytostatic agents: surgical options of treatment]. Damert HG; Lenz-Scharf O; Altmann S; Schneider W Handchir Mikrochir Plast Chir; 2007 Dec; 39(6):409-13. PubMed ID: 18058671 [TBL] [Abstract][Full Text] [Related]
28. Treatment options in extravasation injury: an experimental study in rats. Yilmaz M; Demirdover C; Mola F Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569 [TBL] [Abstract][Full Text] [Related]
29. What is the appropriate management of tissue extravasation by antitumor agents? Larson DL Plast Reconstr Surg; 1985 Mar; 75(3):397-405. PubMed ID: 3883378 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Predictive Validity of Thermography in Identifying Extravasation With Intravenous Chemotherapy Infusions. Matsui Y; Murayama R; Tanabe H; Oe M; Motoo Y; Wagatsuma T; Michibuchi M; Kinoshita S; Sakai K; Konya C; Sugama J; Sanada H J Infus Nurs; 2017; 40(6):367-374. PubMed ID: 29112585 [TBL] [Abstract][Full Text] [Related]
31. Extravasation of chemotherapeutic agents: prevention and treatment. Goolsby TV; Lombardo FA Semin Oncol; 2006 Feb; 33(1):139-43. PubMed ID: 16473651 [TBL] [Abstract][Full Text] [Related]
32. [Management of extravasation of chemotherapeutic agents]. Yamamoto A Gan To Kagaku Ryoho; 2011 Nov; 38(11):1750-2. PubMed ID: 22083178 [TBL] [Abstract][Full Text] [Related]
33. Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic. Sakaida E; Sekine I; Iwasawa S; Kurimoto R; Uehara T; Ooka Y; Akanuma N; Tada Y; Imai C; Oku T; Takiguchi Y Jpn J Clin Oncol; 2014 Feb; 44(2):168-71. PubMed ID: 24302758 [TBL] [Abstract][Full Text] [Related]
34. [Prevention of extravasation necroses as a complication following intravenous cytostatic drug therapy. Results of an open pilot study]. Kolarić K; Zupanc D; Stahl KW; Hinz J; Kempf SR; Ivankovic S Onkologie; 1988 Oct; 11(5):238-40. PubMed ID: 3059251 [TBL] [Abstract][Full Text] [Related]
36. Severe Extravasation Injuries in Neonates: A Report of 34 Cases. Kostogloudis N; Demiri E; Tsimponis A; Dionyssiou D; Ioannidis S; Chatziioannidis I; Nikolaidis N Pediatr Dermatol; 2015; 32(6):830-5. PubMed ID: 26337780 [TBL] [Abstract][Full Text] [Related]
37. A case of mitoxantrone extravasation. Chang A J Oncol Pharm Pract; 2020 Jul; 26(5):1270-1273. PubMed ID: 31902285 [TBL] [Abstract][Full Text] [Related]
38. Emergency treatment of accidental infusion leakage in the newborn: report of 14 cases. Casanova D; Bardot J; Magalon G Br J Plast Surg; 2001 Jul; 54(5):396-9. PubMed ID: 11428769 [TBL] [Abstract][Full Text] [Related]
39. Localized bullous eruptions caused by extravasation of commonly used intravenous infusion fluids. Robijns BJ; de Wit WM; Bosma NJ; van Vloten WA Dermatologica; 1991; 182(1):39-42. PubMed ID: 2013354 [TBL] [Abstract][Full Text] [Related]
40. Early surgical suction and washout for treatment of cytotoxic drug extravasations. Vandeweyer E; Deraemaecker R Acta Chir Belg; 2000 Feb; 100(1):37-8. PubMed ID: 10776527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]